Sermorelin Acetate
Synthetic GHRH analogue for natural growth hormone stimulation research.
Description
Synthetic GHRH analogue for natural growth hormone stimulation research.
Sermorelin acetate is a synthetic 29-amino acid peptide corresponding to the first 29 residues of the 44-amino acid human growth hormone-releasing hormone (GHRH 1-29). It represents the shortest fully functional fragment of GHRH capable of activating the GHRH receptor on anterior pituitary somatotrophs. Sermorelin was FDA-approved (marketed as Geref) for diagnostic evaluation of pituitary GH secretory capacity and was previously used in pediatric growth hormone deficiency research. Its mechanism involves GHRH-R binding, which activates adenylyl cyclase-cAMP-PKA signaling to stimulate GH gene transcription, synthesis, and pulsatile release. Clinical studies by Vittone et al. (Journal of Clinical Endocrinology and Metabolism, 1997) demonstrated that sermorelin administration in elderly subjects increased GH secretion and improved body composition markers including lean body mass and skin thickness. Importantly, because sermorelin works through the native GHRH receptor, GH release remains subject to somatostatin-mediated negative feedback, preserving physiological regulation unlike direct GH administration. Research has also explored sermorelin in cardiovascular contexts, where GH-IGF-1 axis activation may support cardiac tissue remodeling, and in seizure models where GHRH receptor activation appears to have neuroprotective effects. Compared to CJC-1295 (with or without DAC), sermorelin has a shorter half-life of approximately 10-20 minutes, requiring more frequent administration but producing very precise, physiological GH pulses. Store lyophilized powder at -20C; reconstitute with bacteriostatic water and refrigerate at 2-8C for up to 14 days. Sermorelin is studied by pediatric endocrinology research centers, geriatric medicine departments, and cardiovascular research institutions investigating GH axis modulation.
This product is supplied as a lyophilized powder and is intended for laboratory and research use only. Not for human consumption. Each vial contains 10mg of research-grade material.
Research Applications
- Cardiovascular tissue regeneration
- Neurological and seizure research
- Sleep quality improvement studies
- Bone mineral density enhancement
Specifications
- Size
- 10mg
- Purity
- ≥98% (HPLC)
- Form
- Lyophilized Powder
- Molecular Formula
- C187H291N45O59
- Molecular Weight
- 4113.58 g/mol
- CAS Number
- 910463-68-2
Storage & Handling
- Long-term storage: -20°C in a sealed, light-protected container
- Short-term storage: 2-8°C (refrigerated) for up to 30 days
- Reconstituted: Store at 2-8°C and use within 30 days
- Avoid: Repeated freeze-thaw cycles, direct sunlight, and moisture exposure
- Reconstitution: Use bacteriostatic water or sterile water for injection
Frequently Asked Questions
What is Sermorelin Acetate and how does it work?
What research has been done on Sermorelin?
How does Sermorelin compare to CJC-1295 (without DAC)?
What is the recommended reconstitution protocol for Sermorelin?
What purity testing is performed on Sermorelin?
Related Products
CJC-1295 + Ipamorelin
Synergistic GH secretagogue blend for body composition research.
Ipamorelin
Highly selective synthetic pentapeptide GH secretagogue for research.
CJC-1295 (without DAC)
Modified GHRH analogue for growth hormone release research.
Research Use Only. This product is not intended for human consumption, therapeutic use, or diagnostic purposes. All peptides sold by Elyte Peptides are strictly for in-vitro research and laboratory use. By purchasing, you agree to use this product in compliance with all applicable laws and regulations.